-
Intravenous immunoglobulin (IVIg) is an effective treatment for a wide range of autoimmune neurological disorders. IVIg is well tolerated in general but may rarely result in anaphylaxis and acute renal failure, as well as thromboembolic complications such as pulmonary embolism and stroke. These recent reports in Neurology highlight the potential vascular consequences of IVIg.
-
Differentiating central from peripheral causes of vertigo is a recurrent clinical challenge that behooves reinforcement.
-
Current research does not support the use of hypertonic solutions for initial resuscitation of patients with acute traumatic brain injury, but it remains an option for subsequent treatment.
-
In a Phase I/II open-label study of patients with multiple sclerosis and amyotrophic lateral sclerosis, mesenchymal stem cell transplantation was found to be safe and induced an early immunonologic response.
-
Episodes of severe sepsis in older adults is associated with worsening cognition and functional status.
-
In this small clinical trial, supplementation with CoQ 10 did not result in any clinical improvement for patients with mitochondrial disorders.
-
Clinical predictors of mortality in Parkinson's disease include age at onset, chronological age, male sex, motor severity, psychosis, and dementia.
-
How Frequently is Atrial Fibrillation Detected in Patients with Stroke or TIA?
-
-
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
